Trade Summary

5 days ago, Atkinson Edward Morrow III, serving as EVP, Chief Technical Ops. Offi at Vertex Pharmaceuticals Inc / Ma (VRTX), sold 2,848 shares at $484.93 per share, for a total transaction value of $1,381,090.00. Following this transaction, Atkinson Edward Morrow III now holds 20,727 shares of VRTX.

This sale represents a 12.00% decrease in Atkinson Edward Morrow III's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, February 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 19, 2026, 2 days after the trade was made.

Vertex Pharmaceuticals Inc / Ma operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.